IP Library Patent Application 17455322
Patent Application
App. No. 17/455,322

TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY USING PLACENTAL CELLS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/455,322
Abstract

Provided herein are methods of using CD10 + , CD34 − , CD105 + , CD200 + tissue culture plastic-adherent placental cells, e.g. placental stem cells, in the treatment of diabetic peripheral neuropathy (DPN).

Claims (12)

1 . A method of treating a subject having a diabetic peripheral neuropathy, comprising administering to the subject a composition comprising CD10 + , CD34 − , CD105 + , CD200 + placental stem cells, wherein said composition comprising placental stem cells is administered intramuscularly, and wherein said treatment results in an increase in epidermal nerve fiber density in said subject.

2 . The method of claim 1 , wherein said diabetic peripheral neuropathy affects one or more of the hands, feet, arms, or legs of said subject.

3 . The method of claim 1 , wherein said diabetic peripheral neuropathy affects each of the hands, feet, arms, or legs of said subject.

4 . (canceled)

5 . The method of claim 1 , wherein said composition comprises between 1×10 5 to 1×10 6 , 1×10 6 to 3×10 6 , 3×10 6 to 5×10 6 , 5×10 6 to 1×10 7 , 1×10 7 to 3×10 7 , 3×10 7 to 5×10 7 , 5×10 7 to 1×10 8 , 1×10 8 to 3×10 8 , 3×10 8 to 5×10 8 , 5×10 8 to 1×10 9 , 1×10 9 to 5×10 9 , or 5×10 9 to 1×10 10 placental stem cells.

6 . The method of claim 1 , wherein said composition comprises about 1×10 5 , 3×10 5 , 5×10 5 , 1×10 6 , 3×10 6 , 5×10 6 , 1×10 7 , 3×10 7 , 5×10 7 , 1×10 8 , 3×10 8 , 5×10 8 , 1×10 9 , 5×10 9 , or 1×10 10 placental stem cells.

7 . The method of claim 6 , wherein said composition comprises about 3×10 6 placental stem cells.

8 . The method of claim 6 , wherein said composition comprises about 3×10 7 placental stem cells.

9 . (canceled)

10 . The method of claim 1 , wherein said increase in epidermal nerve fiber density in said subject is measured by skin biopsy.

11 . The method of claim 1 , wherein said treatment results in improvement in one or more symptoms of said diabetic peripheral neuropathy.

12 . The method of claim 11 , wherein said one or more symptoms is numbness or reduced ability to feel pain or temperature changes, a tingling or burning sensation in the limbs, sharp pains or cramps, increased sensitivity to touch, muscle weakness, loss of reflexes (e.g., in the ankle), loss of balance and/or coordination, and/or foot problems (such as ulcers, infections, deformities, and bone and joint pain).

Assignments (2)
MERGER Recorded Feb 24, 2023
From: ANTHROGENESIS CORPORATION
To: CLARITY ACQUISITION II LLC
Reel/Frame 062795/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2023
From: CLARITY ACQUSITION II LLC
To: CELULARITY INC.
Reel/Frame 062852/0750 →